Correlation Between Bio Gene and Richmond Vanadium

Can any of the company-specific risk be diversified away by investing in both Bio Gene and Richmond Vanadium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Gene and Richmond Vanadium into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bio Gene Technology and Richmond Vanadium Technology, you can compare the effects of market volatilities on Bio Gene and Richmond Vanadium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Gene with a short position of Richmond Vanadium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Gene and Richmond Vanadium.

Diversification Opportunities for Bio Gene and Richmond Vanadium

0.76

Correlation Coefficient

Bio Gene  Richmond Vanadium

Poor diversification

The 3 months correlation between Bio and Richmond is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Bio Gene Technology and Richmond Vanadium Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Richmond Vanadium and Bio Gene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Gene Technology are associated (or correlated) with Richmond Vanadium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Richmond Vanadium has no effect on the direction of Bio Gene i.e., Bio Gene and Richmond Vanadium go up and down completely randomly.

Pair Corralation between Bio Gene and Richmond Vanadium

Assuming the 90 days trading horizon Bio Gene Technology is expected to generate 0.94 times more return on investment than Richmond Vanadium. However, Bio Gene Technology is 1.06 times less risky than Richmond Vanadium. It trades about -0.03 of its potential returns per unit of risk. Richmond Vanadium Technology is currently generating about -0.11 per unit of risk. If you would invest  4.40  in Bio Gene Technology on September 19, 2024 and sell it today you would lose (0.60) from holding Bio Gene Technology or give up 13.64% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Bio Gene Technology  vs.  Richmond Vanadium Technology

Bio Gene Technology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bio Gene Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Richmond Vanadium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Richmond Vanadium Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Bio Gene and Richmond Vanadium

The main advantage of trading using opposite Bio Gene and Richmond Vanadium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Gene position performs unexpectedly, Richmond Vanadium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Richmond Vanadium will offset losses from the drop in Richmond Vanadium's long position.

The idea behind Bio Gene Technology and Richmond Vanadium Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.